[ad_1]
Rapid testing is also expected to be performed in cases where a person experiences clear clinical signs of coronavirus infection, but repeated PCR testing is negative, according to the press release.
According to the Minister of Health, Aurelijus Veryga, Head of State Operations in a State of Emergency, this decision is based on the scientists’ findings and their recommendations on how to use these tests so that they are not confused and do not have the opposite effect.
“In order for the tests not to be misleading, there must be clear situations and rules on when they can be used. The research carried out by scientists and experts allowed to dispel all the doubts that had existed until then and make decisions based on science. Therefore, there should be no room for manipulation for precision. I thank everyone who contributed to finding answers to questions about the use of rapid serological tests that everyone has faced, “says Minister A. Veryga.
In any event, these rapid tests are expected to be used in conjunction with molecular testing using the PCR method, i. and. taking a sample from the nasopharynx.
It is also important that rapid tests are for professional use only, and results are evaluated and interpreted by healthcare professionals. So, at home, without a health professional it should not be used. As a result, the Ministry of Health (SAM) has approached the State Service for the Protection of Consumer Rights (SCRPA) to evaluate the possibility of changing the legal framework to prevent rapid tests from being marketed online.
SAM recalls that researchers and experts from the University of Vilnius (VU) and the Santara Clinics, who carried out a biomedical study, concluded that the serological tests of both manufacturers, both quantitative (IgG / IgA) and rapid (IgG / IgM), they should not be used for acute coronavirus to diagnose infection. In other words, they are not suitable for the early diagnosis of COVID-19 because the sensitivity of the tests is too low. According to the scientists, serological tests should be used to verify whether a person has a coronavirus infection or not, i. and. to determine the so-called seroconversion.
The study confirmed that the AMP SARS-CoV-2 IgG / IgM Rapid Assays have a similar sensitivity to Euroimmun’s quantitative SARS-CoV-2 IgG / IgM Rapid Assays and SARS-CoV-2 IgG Rapid Assays. InTec used for comparison. It is less sensitive.
The National Public Health Laboratory (NVSPL) has acquired manufacturer testing for AMP.
It is strictly prohibited to use the information published by DELFI on other websites, in the media or elsewhere, or to distribute our material in any way without consent, and if consent has been obtained, DELFI must be cited as the source.
[ad_2]
